END-STAGE LIVER DISEASE (ESLD)
Clinical trials for END-STAGE LIVER DISEASE (ESLD) explained in plain language.
Never miss a new study
Get alerted when new END-STAGE LIVER DISEASE (ESLD) trials appear
Sign up with your email to follow new studies for END-STAGE LIVER DISEASE (ESLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Living Medicine' made from Patient's own cells to fight liver failure
Disease control Recruiting nowThis is the first study in people to test a new personalized cell therapy called RTX001 for advanced liver disease. The therapy is made by collecting a patient's own white blood cells, engineering them in a lab to potentially reduce liver scarring and inflammation, and then retur…
Matched conditions: END-STAGE LIVER DISEASE (ESLD)
Phase: PHASE1, PHASE2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Major trial aims to tame transplant bleeding without causing clots
Disease control Recruiting nowThis large study is testing if a drug called tranexamic acid (TXA) can safely reduce dangerous blood loss during liver transplant surgery. Over 1500 adult patients receiving a transplant will be randomly given either TXA or a placebo (saltwater) during their operation. The main g…
Matched conditions: END-STAGE LIVER DISEASE (ESLD)
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC